Related Experiment Video
Updated: Aug 13, 2026

Direct-current Stimulation and Multi-electrode Array Recording of Seizure-like Activity in Mice Brain Slice Preparation
Published on: June 7, 2016
[Therapy of brain-related minor seizures]
1Neurologische Universitätsklinik, Inselspital, Bern.
Abstract:
The pharmacotherapy of minor seizures depends on the type of epileptic manifestation. Generalized minor seizures (petit-mal) must be differentiated from focal (partial) seizures. The former are further divided into the typical absence attacks of childhood and benign myoclonic seizures. The drug of choice for both forms of generalized minor seizures is valproate, which also has the advantage of being reliably effective against the frequently associated grand-mal seizures. The focal seizures' epileptic activity is either in the neocortex (simple partial seizures) or in the limbic system (complex partial seizures). Neocortical focal seizures are characterized by motor jerks in one limb (Jacksonian type), head turning (adversive attack), or localized sensory manifestations, and limbic or psychomotor attacks by brief impairment of consciousness and often by motor automatisms. Focal seizures, which are sometimes difficult to control, are best treated with carbamazepine or phenytoin.
More Related Videos
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Electroconvulsive Therapy
Seizures l: Introduction

